Literature DB >> 19430199

Epigenetic analysis of childhood acute lymphoblastic leukemia.

Thomas L Dunwell1, Luke B Hesson, Tatiana Pavlova, Veronika Zabarovska, Vladimir Kashuba, Daniel Catchpoole, Raffaella Chiaramonte, Anna T Brini, Mike Griffiths, Eamonn R Maher, Eugene Zabarovsky, Farida Latif.   

Abstract

We used a chromosome 3 wide NotI microarray for identification of epigenetically inactivated genes in childhood acute lymphoblastic leukemia (ALL). Three novel genes demonstrated frequent methylation in childhood ALL. PPP2R3A (protein phosphatase 2, regulatory subunit B", alpha) was frequently methylated in T (69%) and B (82%)-ALL. Whilst FBLN2 (fibulin 2) and THRB (thyroid hormone receptor, beta) showed frequent methylation in B-ALL (58%; 56% respectively), but were less frequently methylated in T-ALL (17% for both genes). Recently it was demonstrated that BNC1 (Basonuclin 1) and MSX1 (msh homeobox 1) were frequently methylated across common epithelial cancers. In our series of childhood ALL BNC1 was frequently methylated in both T (77%) and B-ALL (79%), whilst MSX1 showed T-ALL (25%) specific methylation. The methylation of the above five genes was cancer specific and expression of the genes could be restored in methylated leukemia cell lines treated with 5-aza-2'-deoxycytidine. This is the first report demonstrating frequent epigenetic inactivation of PPP2R3A, FBLN2, THRB, BNC1 and MSX1 in leukemia. The identification of frequently methylated genes showing cancer specific methylation will be useful in developing early cancer detection screens and for targeted epigenetic therapies.

Entities:  

Mesh:

Year:  2009        PMID: 19430199     DOI: 10.4161/epi.4.3.8752

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  41 in total

1.  The expression level of fibulin-2 in the circulating RNA (ctRNA) of epithelial tumor cells of peripheral blood and tumor tissue of patients with metastatic lung cancer.

Authors:  Mukaddes Avsar; Makbule Tambas; Zubeyde Yalniz; Demet Akdeniz; Seref Bugra Tuncer; Seda Kilic; Ozge Sukruoglu Erdogan; Rumeysa Ciftci; Nergiz Dagoglu; Sezai Vatansever; Hulya Yazici
Journal:  Mol Biol Rep       Date:  2019-05-08       Impact factor: 2.316

2.  Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms.

Authors:  Cristina Pérez; Marien Pascual; José Ignacio Martín-Subero; Beatriz Bellosillo; Victor Segura; Eric Delabesse; Sara Álvarez; María José Larrayoz; José Rifón; Juan Cruz Cigudosa; Carles Besses; María José Calasanz; Nicholas C P Cross; Felipe Prósper; Xabier Agirre
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

3.  Identification of 5 novel genes methylated in breast and other epithelial cancers.

Authors:  Victoria K Hill; Luke B Hesson; Temuujin Dansranjavin; Ashraf Dallol; Ivan Bieche; Sophie Vacher; Stella Tommasi; Timothy Dobbins; Dean Gentle; David Euhus; Cheryl Lewis; Reinhard Dammann; Robyn L Ward; John Minna; Eammon R Maher; Gerd P Pfeifer; Farida Latif
Journal:  Mol Cancer       Date:  2010-03-05       Impact factor: 27.401

4.  A genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers.

Authors:  Thomas Dunwell; Luke Hesson; Tibor A Rauch; Lihui Wang; Richard E Clark; Ashraf Dallol; Dean Gentle; Daniel Catchpoole; Eamonn R Maher; Gerd P Pfeifer; Farida Latif
Journal:  Mol Cancer       Date:  2010-02-25       Impact factor: 27.401

5.  TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome.

Authors:  P Villarese; C Lours; A Trinquand; S Le Noir; M Belhocine; L Lhermitte; A Cieslak; M Tesio; A Petit; M LeLorch; S Spicuglia; N Ifrah; H Dombret; A W Langerak; N Boissel; E Macintyre; V Asnafi
Journal:  Leukemia       Date:  2017-06-08       Impact factor: 11.528

Review 6.  Genetic features of thyroid hormone receptors.

Authors:  Maha Rebaï; Imen Kallel; Ahmed Rebaï
Journal:  J Genet       Date:  2012       Impact factor: 1.166

7.  Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.

Authors:  Vera N Senchenko; Ekaterina A Anedchenko; Tatiana T Kondratieva; George S Krasnov; Alexei A Dmitriev; Veronika I Zabarovska; Tatiana V Pavlova; Vladimir I Kashuba; Michael I Lerman; Eugene R Zabarovsky
Journal:  BMC Cancer       Date:  2010-03-01       Impact factor: 4.430

8.  Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Authors:  Vera N Senchenko; Natalia P Kisseljova; Tatyana A Ivanova; Alexey A Dmitriev; George S Krasnov; Anna V Kudryavtseva; Grigory V Panasenko; Evgeny B Tsitrin; Michael I Lerman; Fyodor L Kisseljov; Vladimir I Kashuba; Eugene R Zabarovsky
Journal:  Epigenetics       Date:  2013-03-11       Impact factor: 4.528

Review 9.  The epigenome as a potential mediator of cancer and disease prevention in prenatal development.

Authors:  Pushpinder Kaur; Lyndsey E Shorey; Emily Ho; Roderick H Dashwood; David E Williams
Journal:  Nutr Rev       Date:  2013-05-15       Impact factor: 7.110

10.  Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment.

Authors:  Yogita Kanan; Daniel Brobst; Zongchao Han; Muna I Naash; Muayyad R Al-Ubaidi
Journal:  J Biol Chem       Date:  2014-04-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.